drugset / Trial / NCT02213497

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

NCT02213497 ↗

Phase 1 Active not recruiting 30 enrolled Abramson Cancer Center at Penn Medicine
NaSequentialOpen-labelDiagnostic

Summary

Patients with esophageal cancer to be treated with concurrent preoperative proton therapy along with carboplatin and paclitaxel.

Timeline

Start
2014-04
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Paclitaxel Small molecule — —

Indications